Showing results (101-110 of 451) with videos related to
Sort By:
Pageof 46
Gastroenterology|March 1, 2015
Trough concentrations of infliximab guide dosing for patients with inflammatory bowel diseaseNiels Vande Casteele, Marc Ferrante, Gert Van Assche, et al.Inflammatory Bowel Diseases|September 9, 2017
Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel DiseaseMaaike Vancamelbeke, Tim Vanuytsel, Ricard Farré, et al.Journal of Crohn'S & Colitis|September 11, 2019
Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naïve and Anti-TNF Exposed IBD PatientsBram Verstockt, Evelien Mertens, Erwin Dreesen, et al.The American Journal of Gastroenterology|November 14, 2012
Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healingTalat Bessissow, Bart Lemmens, Marc Ferrante, et al.Scientific Reports|July 13, 2019
Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13Brecht Creyns, Jonathan Cremer, Tomoaki Hoshino, et al.Journal of Clinical Gastroenterology|December 3, 2019
Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease PatientsIris Detrez, Debby Thomas, Kristel Van Steen, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 6, 2014
Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remissionKonstantinos Papamichael, Niels Vande Casteele, Ann Gils, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 29, 2018
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel DiseasesErwin Dreesen, Bram Verstockt, Sumin Bian, et al.Inflammatory Bowel Diseases|August 11, 2011
Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapyFabian Schnitzler, Herma Fidder, Marc Ferrante, et al.Inflammatory Bowel Diseases|May 30, 2014
Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitisMagali de Bruyn, Ingrid Arijs, Willem-Jan Wollants, et al.Pageof 46